The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

INTRODUCTION: Ductal carcinoma in situ (DCIS) is a non-invasive non-obligate precursor of invasive breast cancer. With guideline concordant care (GCC), DCIS outcomes are at least as favourable as some other early stage cancer types such as prostate cancer, for which active surveillance (AS) is a sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, E Shelley, Hyslop, Terry, Lynch, Thomas, Frank, Elizabeth, Pinto, Donna, Basila, Desiree, Collyar, Deborah, Bennett, Antonia, Kaplan, Celia, Rosenberg, Shoshana, Thompson, Alastair, Weiss, Anna, Partridge, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Patient-Centred Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429899/
https://www.ncbi.nlm.nih.gov/pubmed/30862637
http://dx.doi.org/10.1136/bmjopen-2018-026797

Ejemplares similares

Ejemplares similares